Article
Skipping the co-expression problem: the new 2A "CHYSEL" technology
13 Sept 2004
Abstract excerpt
The rapid progress in the field of genomics is increasing our knowledge of multi-gene diseases. However, any realistic hope of gene therapy treatment for those diseases needs first to address the problem of co-ordinately co-expressing several transgenes. Currently, the use of internal ribosomal entry sites (IRESs) is the strategy chosen by many researchers to ensure co-expression. The large sizes of the IRESs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
